{"id":174450,"name":"PROLACTA BIOSCIENCE, INC.","slug":"prolacta-bioscience-inc","state":"CA","description":"Standardized human milk-based nutritional products for premature infants in the NICU","totalSpending":2240000,"filings":31,"yearlySpending":[{"year":2018,"income":400000},{"year":2019,"income":320000},{"year":2020,"income":240000},{"year":2021,"income":300000},{"year":2022,"income":320000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":180000}],"firms":["TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)"],"lobbyists":["LIESL GREBENSTEIN SHEEHAN","DAVID GARRIEPY","MALIA CHING"],"issues":["HCR","FOO","BUD",null],"sampleDescriptions":["LHHS Appropriations, FDA appropriations","LHHS Appropriations; FDA industry oversight.","Baby Food Safety Act of 2021; FDA Appropriations; FDA industry oversight.","Advocacy on safety of the human milk industry.","Advocacy on safety of the human milk industry. HR 7358, Donor Milk Safety Act","FY23 Appropriations","Donor Milk Safety Act; Access to Donor Milk Act; FDA Appropriations; FDA industry oversight.","Advocacy in support of safety in human milk market. Access to Donor Milk Act.","FDA Appropriations; FDA industry oversight.","FY24 Appropriations.","FY25 Appropriations.","Advocacy in support of safety in human milk market. Access to Donor Milk Act. Infant formula and HR 2300.","Appropriations","Appropriations."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}